Evaluating triggers and enhancers of tau fibrillization

Microscopy Research and Technique

Volumn 67, Issue 3-4, 2005, Pages 141-155

  Kuret, Jeff ^a,c   Congdon, Erin E ^b   Li, Guibin ^a   Yin, Haishan ^b   Yu, Xian ^b   Zhong, Qi ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Aggregation; Alzheimer's disease; Phosphorylation; Posttranslational modification; Tau

Indexed keywords

BRAIN; FREE ENERGY; NEURODEGENERATIVE DISEASES; NUCLEATION; PROTEINS;

ALZHEIMERS DISEASE; BRAIN REGIONS; DISEASE PROGRESSION; FIBRILLIZATION; FILAMENT FORMATION; MEMORY RETENTION; POST-TRANSLATIONAL MODIFICATIONS; ROBUST MARKERS; TAU; TAU PROTEINS;

BIOLOGICAL SYSTEMS;

DYE; MONOMER; POLYMER; TAU PROTEIN; THIOFLAVINE;

ALZHEIMER DISEASE; DEMENTIA; DISEASE COURSE; ENERGY; FLUORESCENCE; GENE MUTATION; HUMAN; IMAGE ANALYSIS; KINETICS; LASER; LIGHT SCATTERING; MEMORY CONSOLIDATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REACTION ANALYSIS; REVIEW; SEDIMENTATION; THERMODYNAMICS;

EID: 24144459823     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.20187     Document Type: Review

References (160)

1. Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, Kuret J, Binder LI. 2000. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci 113:3737-3745.
2. Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL. 2004. Stimulation of insulin fibrillation by urea-induced intermediates. J Biol Chem 279:14999-15013.
3. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. 2001. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98:6923-6928.
4. Alonso A, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K. 2004. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 279:34873-34881.
5. Arrasate M, Perez M, Armas-Portela R, Avila J. 1999. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Lett 446:199-202.
6. Asakura S, Eguchi G, Iino T. 1964. Reconstitution of bacterial flagella in vitro. J Mol Biol 10:42-56.
7. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. 2002. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (Berl) 103:26-35.
8. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM. 1989. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477:90-99.
9. Barghorn S, Mandelkow E. 2002. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41:14885-14896.
10. Barghorn S, Zheng-Fischhofer Q, Ackmann M, Biernat J, von Bergen M, Mandelkow EM, Mandelkow E. 2000. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39:11714-11721.
11. Barghorn S, Davies P, Mandelkow E. 2004. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain. Biochemistry 43:1694-1703.
12. Berriman J, Serpell LC, Oberg KA, Fink AL, Goedert M, Crowther RA. 2003. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc Natl Acad Sci U S A 100:9034-9038.
13. Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, Cryns VL, Binder LI. 2003. Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Biochemistry 42:8325-8331.
14. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153-163.
15. Bloomfield VA. 2000. Static and dynamic light scattering from aggregating particles. Biopolymers 54:168-172.
16. Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M. 1994. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 53:158-164.
17. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM. 1993. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089-1099.
18. Bruns G, Beerhalter H. 1955. Dye analysis. The fluorochrome mixture, thioflavine S. Acta Histochem 1:254-271.
19. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. 2000. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95-130.
20. Calamai M, Taddei N, Stefani M, Ramponi G, Chiti F. 2003. Relative influence of hydrophobicity and net charge in the aggregation of two homologous proteins. Biochemistry 42:15078-15083.
21. Callahan LM, Coleman PD. 1995. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol Aging 16:311-314.
22. Carmel G, Mager EM, Binder LI, Kuret J. 1996. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 271:32789-32795.
23. Carter DB, Chou KC. 1998. A model for structure-dependent binding of Congo red to Alzheimer beta-amyloid fibrils. Neurobiol Aging 19:37-40.
24. Chen S, Ferrone FA, Wetzel R. 2002. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A 99:11884-11889.
25. Chi EY, Krishnan S, Kendrick BS, Chang BS, Carpenter JF, Randolph TW. 2003. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor. Protein Sci 12:903-913.
26. Chirita CN, Kuret J. 2004. Evidence for an intermediate in tau filament formation. Biochemistry 43:1704-1714.
27. Chirita CN, Necula M, Kuret J. 2003. Anionic micelles and vesicles induce tau fibrillization in vitro. J Biol Chem 278:25644-25650.
28. Chirita CN, Necula M, Kuret J. 2004. Ligand-dependent inhibition and reversal of tau filament formation. Biochemistry 43:2879-2887.
29. Chirita CN, Congdon EE, Yin H, Kuret J. 2005. Triggers of full-length tau aggregation: a role for partially folded intermediates. Biochemistry 44:5862-5872.
30. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. 1999. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A 96:3590-3594.
31. Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424:805-808.
32. Cleveland DW, Hwo SY, Kirschner MW. 1977. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116:227-247.
33. Crowther RA. 1991. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci U S A 88:2288-2292.
34. Crowther RA, Olesen OF, Smith MJ, Jakes R, Goedert M. 1994. Assembly of Alzheimer-like filaments from full-length tau protein. FEBS Lett 337:135-138.
35. Drubin DG, Feinstein SC, Shooter EM, Kirschner MW. 1985. Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J Cell Biol 101:1799-1807.
36. Edelstein-Keshet L, Ermentrout GB. 1998. Models for the length distributions of actin filaments. I. Simple polymerization and fragmentation. Bull Math Biol 60:449-475.
37. Eidenmuller J, Fath T, Hellwig A, Reed J, Sontag E, Brandt R. 2000. Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins. Biochemistry 39:13166-13175.
38. Eidenmuller J, Fath T, Maas T, Pool M, Sontag E, Brandt R. 2001. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem J 357:759-767.
39. Fath T, Eidenmuller J, Brandt R. 2002. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 22:9733-9741.
40. Ferrone F. 1999. Analysis of protein aggregation kinetics. Methods Enzymol 309:256-274.
41. France J, Thornley JHM. 1984. Mathematical models in agriculture. London: Butterworths.
42. Frieden C, Goddette DW. 1983. Polymerization of actin and actin-like systems: evaluation of the time course of polymerization in relation to the mechanism. Biochemistry 22:5836-5843.
43. Friedhoff P, Schneider A, Mandelkow EM, Mandelkow E. 1998a. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 37:10223-10230.
44. Friedhoff P, von Bergen M, Mandelkow EM, Davies P, Mandelkow E. 1998b. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci U S A 95:15712-15717.
45. Galvan M, David JP, Delacourte A, Luna J, Mena R. 2001. Sequence of neurofibrillary changes in aging and Alzheimer's disease: a confocal study with phospho-tau antibody, AD2. J Alzheimers Dis 3:417-425.
46. Gamblin TC, King ME, Dawson H, Vitek MP, Kuret J, Berry RW, Binder LI. 2000. In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. Biochemistry 39:6136-6144.
47. Gamblin TC, Berry RW, Binder LI. 2003a. Tau polymerization: role of the amino terminus. Biochemistry 42:2252-2257.
48. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL. 2003b. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100:10032-10037.
49. Garcia-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI. 2003. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimers Dis 5:65-77.
50. Gazit E. 2002. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J 16:77-83.
51. Ghoshal N, Garcia-Sierra F, Wuu J, Leurgans S, Bennett DA, Berry RW, Binder LI. 2002. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 177:475-493.
52. Goux WJ. 2002. The conformations of filamentous and soluble tau associated with Alzheimer paired helical filaments. Biochemistry 41:13798-137806.
53. Goux WJ, Kopplin L, Nguyen AD, Leak K, Rutkofsky M, Shanmuganandam VD, Sharma D, Inouye H, Kirschner DA. 2004. The formation of straight and twisted filaments from short tau peptides. J Biol Chem 279:26868-26875.
54. Govaerts C, Wille H, Prusiner SB, Cohen FE. 2004. Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A 101:8342-8347.
55. Gray EG, Paula-Barbosa M, Roher A. 1987. Alzheimer's disease: paired helical filaments and cytomembranes. Neuropathol Appl Neurobiol 13:91-110.
56. Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, Horowitz PM, Fu Y, Wang T, Cahill ME, Bigio EH, Berry RW, Binder LI. 2005. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease. Neurobiol Aging 26:1015-1022.
57. Haase C, Stieler JT, Arendt T, Holzer M. 2004. Pseudophosphorylation of tau protein alters its ability for self-aggregation. J Neurochem 88:1509-1520.
58. Hall GF, Yao J. 2000. Neuronal morphology, axonal integrity, and axonal regeneration in situ are regulated by cytoskeletal phosphorylation in identified lamprey central neurons. Microsc Res Tech 48:32-46.
59. Hall GF, Lee VM, Lee G, Yao J. 2001. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. Am J Pathol 158:235-246.
60. Hanger DP, Betts JC, Loviny TL, Blackstock WP, Anderton BH. 1998. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J Neurochem 71:2465-2476.
61. Harper JD, Lansbury Jr PT. 1997. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 66:385-407.
62. Hasegawa M, Crowther RA, Jakes R, Goedert M. 1997. Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J Biol Chem 272:33118-33124.
63. Hiraoka S, Yao TM, Minoura K, Tomoo K, Sumida M, Taniguchi T, Ishida T. 2004. Conformational transition state is responsible for assembly of microtubule-binding domain of tau protein. Biochem Biophys Res Commun 315:659-663.
64. Hogg M, Grujic ZM, Baker M, Demirci S, Guillozet AL, Sweet AP, Herzog LL, Weintraub S, Mesulam MM, LaPointe NE, Gamblin TC, Berry RW, Binder LI, de Silva R, Lees A, Espinoza M, Davies P, Grover A, Sahara N, Ishizawa T, Dickson D, Yen SH, Hutton M, Bigio EH. 2003. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathol (Berl) 106:323-336.
65. Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, Bellmann C, Richter-Landsberg C, Lee VM, Trojanowski JQ. 2003. Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 163:1021-1031.
66. Hurshman AR, White JT, Powers ET, Kelly JW. 2004. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43:7365-7381.
67. Ingram EM, Spillantini MG. 2002. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol Med 8:555-562.
68. Iqbal K, Zaidi T, Thompson CH, Merz PA, Wisniewski HM. 1984. Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol (Berl) 62:167-177.
69. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VM. 1999. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24:751-762.
70. Jarrett JT, Lansbury Jr PT. 1993. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058.
71. Jin LW, Claborn KA, Kurimoto M, Geday MA, Maezawa I, Sohraby F, Estrada M, Kaminksy W, Kahr B. 2003. Imaging linear birefringence and dichroism in cerebral amyloid pathologies. Proc Natl Acad Sci USA 100:15294-15298.
72. Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E. 1996. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 399:344-349.
73. Kayed R, Bernhagen J, Greenfield N, Sweimeh K, Brunner H, Voelter W, Kapurniotu A. 1999. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol 287:781-796.
74. Kenessey A, Yen SH. 1993. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res 629:40-46.
75. Khatoon S, Grundke-Iqbal I, Iqbal K. 1992. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59:750-753.
76. Khurana R, Gillespie JR, Talapatra A, Minert LJ, Ionescu-Zanetti C, Millett I, Fink AL. 2001a. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40:3525-3535.
77. Khurana R, Uversky VN, Nielsen L, Fink AL. 2001b. Is Congo red an amyloid-specific dye? J Biol Chem 276:22715-22721.
78. Kim YS, Randolph TW, Manning MC, Stevens FJ, Carpenter JF. 2003. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation. J Biol Chem 278:10842-10850.
79. Kimura T, Ono T, Takamatsu J, Yamamoto H, Ikegami K, Kondo A, Hasegawa M, Ihara Y, Miyamoto E, Miyakawa T. 1996. Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia 7:177-181.
80. King ME, Ahuja V, Binder LI, Kuret J. 1999. Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry 38:14851-14859.
81. King ME, Gamblin TC, Kuret J, Binder LI. 2000. Differential assembly of human tau isoforms in the presence of arachidonic acid. J Neurochem 74:1749-1757.
82. King ME, Ghoshal N, Wall JS, Binder LI, Ksiezak-Reding H. 2001. Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments. Am J Pathol 158:1481-1490.
83. Ko LW, DeTure M, Sahara N, Chihab R, Yen SH. 2002. Cellular models for tau filament assembly. J Mol Neurosci 19:311-316.
84. Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I. 1993. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374-24384.
85. Krebs MR, Bromley EH, Donald AM. 2005. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J Struct Biol 149: 30-37.
86. Kristofferson D, Purich DL. 1981. Time scale of microtubule length redistribution. Arch Biochem Biophys 211:222-226.
87. Kristofferson D, Karr TL, Purich DL. 1980. Dynamics of linear protein polymer disassembly. J Biol Chem 255:8567-8572.
88. Ksiezak-Reding H, Wall JS. 1994. Mass and physical dimensions of two distinct populations of paired helical filaments. Neurobiol Aging 15:11-19.
89. Ksiezak-Reding H, Liu WK, Yen SH. 1992. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res 597:209-219.
90. Ledesma MD, Bonay P, Avila J. 1995. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 65:1658-1664.
91. Leger J, Kempf M, Lee G, Brandt R. 1997. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J Biol Chem 272:8441-8446.
92. LeVine 3rd H. 1993. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2:404-410.
93. LeVine 3rd H. 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309:274-84.
94. Li L, von Bergen M, Mandelkow EM, Mandelkow E. 2002. Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis. J Biol Chem 277:41390-41400.
95. Li G, Yin H, Kuret J. 2004. Casein kinase 1 delta phosphorylates Tau and disrupts its binding to microtubules. J Biol Chem 279:15938-15945.
96. Luo J, He R, Li W. 2000. The fluorescent characterization of the polymerized microtubule-associated protein Tau. Int J Biol Macromol 27:263-268.
97. Matsuo ES, Shin RW, Billingsley ML, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM. 1994. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13:989-1002.
98. Mena R, Edwards PC, Harrington CR, Mukaetova-Ladinska EB, Wischik CM. 1996. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol (Berl) 91:633-641.
99. Minoura K, Tomoo K, Ishida T, Hasegawa H, Sasaki M, Taniguchi T. 2002. Amphipathic helical behavior of the third repeat fragment in the tau microtubule-binding domain, studied by (1)H NMR spectroscopy. Biochem Biophys Res Commun 294:210-214.
100. Minoura K, Tomoo K, Ishida T, Hasegawa H, Sasaki M, Taniguchi T. 2003. Solvent-dependent conformation of the third repeat fragment in the microtubule-binding domain of tau protein, analyzed by H-1-NMR spectroscopy and molecular modeling calculation. Bull Chem Soc Jpn 76:1617-1624.
101. Minoura K, Yao TM, Tomoo K, Sumida M, Sasaki M, Taniguchi T, Ishida T. 2004. Different associational and conformational behaviors between the second and third repeat fragments in the tau microtubule-binding domain. Eur J Biochem 271:545-552.
102. Montejo de Garcini E, Avila J. 1987. In vitro conditions for the self-polymerization of the microtubule-associated protein, tau factor. J Biochem (Tokyo) 102:1415-1421.
103. Montejo de Garcini E, Carrascosa JL, Correas I, Nieto A, Avila J. 1988. Tau factor polymers are similar to paired helical filaments of Alzheimer's disease. FEBS Lett 236:150-154.
104. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Titani K, Ihara Y. 1995. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 270:823-829.
105. Morsch R, Simon W, Coleman PD. 1999. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188-197.
106. Naiki H, Gejyo F. 1999. Kinetic analysis of amyloid fibril formation. Methods Enzymol 309:305-318.
107. Naiki H, Nakakuki K. 1996. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab Invest 74:374-383.
108. Necula M, Kuret J. 2004a. Electron microscopy as a quantitative method for investigating tau fibrillization. Anal Biochem 329:238-246.
109. Necula M, Kuret J. 2004b. Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. J Biol Chem 279:49694-49703.
110. Necula M, Kuret J. 2004c. A static laser light scattering assay for surfactant-induced tau fibrillization. Anal Biochem 333:205-215.
111. Necula M, Kuret J. 2005. Site-specific pseudophosphorylation modulates the rate of tau filament dissociation. FEBS Lett 579:1453-1457.
112. Necula M, Chirita CN, Kuret J. 2003. Rapid anionic micelle-mediated α-synuclein fibrillization in vitro. J Biol Chem 278:46674-46680.
113. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, Vyas S, Uversky VN, Fink AL. 2001. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40:6036-6046.
114. Novak M, Kabat J, Wischik CM. 1993. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12:365-370.
115. Oosawa F, Asakura S. 1975. Thermodynamics of the polymerization of protein. New York: Academic Press.
116. Outeiro TF, Lindquist S. 2003. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302:1772-1775.
117. Padrick SB, Miranker AD. 2002. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 41:4694-4703.
118. Pallitto MM, Murphy RM. 2001. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J 81:1805-1822.
119. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-22.
120. Perez M, Valpuesta JM, Medina M, Montejo de Garcini E, Avila J. 1996. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem 67:1183-1190.
121. Perez M, Arrasate M, Montejo De Garcini E, Munoz V, Avila J. 2001. In vitro assembly of tau protein: mapping the regions involved in filament formation. Biochemistry 40:5983-5991.
122. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. 2002. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A 99:16742-16747.
123. Pickhardt M, Gazova Z, von Bergen M, Khlistunova I, Wang Y, Hascher A, Mandelkow EM, Biernat J, Mandelkow E. 2005. Anthraquinones inhibit tau aggregation and dissolve alzheimer paired helical filaments in vitro and in cells. J Biol Chem 280:3628-3635.
124. Randolph AD, Larson MA. 1988. Theory of particulate processes: analysis and techniques of continuous crystallization. San Diego: Academic Press.
125. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW. 2004. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114:121-130.
126. Royall DR, Palmer R, Mulroy AR, Polk MJ, Roman GC, David JP, Delacourte A. 2002. Pathological determinants of the transition to clinical dementia in Alzheimer's disease. Exp Aging Res 28:143-162.
127. Rubenstein R, Kascsak RJ, Merz PA, Wisniewski HM, Carp RI, Iqbal K. 1986. Paired helical filaments associated with Alzheimer disease are readily soluble structures. Brain Res 372:80-88.
128. Sadqi M, Hernandez F, Pan U, Perez M, Schaeberle MD, Avila J, Munoz V. 2002. Alpha-helix structure in Alzheimer's disease aggregates of tau-protein. Biochemistry 41:7150-7155.
129. Sato S, Tatebayashi Y, Akagi T, Chui DH, Murayama M, Miyasaka T, Planel E, Tanemura K, Sun X, Hashikawa T, Yoshioka K, Ishiguro K, Takashima A. 2002. Aberrant tau phosphorylation by GSK-3b and JNK-3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem 277:42060-42065.
130. Schmittschmitt JP, Scholtz JM. 2003. The role of protein stability, solubility, and net charge in amyloid fibril formation. Protein Sci 12:2374-2378.
131. Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM. 1999. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38: 3549-3558.
132. Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E. 1994. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J Biol Chem 269:24290-24297.
133. Schweers O, Mandelkow EM, Biernat J, Mandelkow E. 1995. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci U S A 92:8463-8467.
134. Sciarretta KL, Gordon DJ, Petkova AT, Tycko R, Meredith SC. 2005. Aβ40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry 44:6003-6014.
135. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, Lindquist SL. 2000. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289:1317-1321.
136. Seubert P, Mawal-Dewan M, Barbour R, Jakes R, Goedert M, Johnson GV, Litersky JM, Schenk D, Lieberburg I, Trojanowski JQ, et al. 1995. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 270:18917-18922.
137. Shorter J, Lindquist S. 2004. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304: 1793-1797.
138. Smith DP, Jones S, Serpell LC, Sunde M, Radford SE. 2003. A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. J Mol Biol 330:943-954.
139. Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, Geerts H, Mercken M, Sciot R, Van Lommel A, Loos R, Van Leuven F. 1999. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155:2153-2165.
140. Syme CD, Blanch EW, Holt C, Jakes R, Goedert M, Hecht L, Barron LD. 2002. A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. Eur J Biochem 269:148-156.
141. Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M. 2005. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280:7614-7623.
142. Timasheff SN. 1981. The self-assembly of long rodlike structures. In: Nichol LW, editor. Protein-protein interactions. New York: John Wiley & Sons. p 315-336.
143. Uversky VN, Fink AL. 2004. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698:131-153.
144. Uversky VN, Lee HJ, Li J, Fink AL, Lee SJ. 2001a. Stabilization of partially folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations. J Biol Chem 276:43495-43498.
145. Uversky VN, Li J, Fink AL. 2001b. Evidence for a partially folded intermediate in α-synuclein fibril formation. J Biol Chem 276: 10737-10744.
146. Uversky VN, Li J, Fink AL. 2001c. Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 276:44284-44296.
147. von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E. 2001. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 276:48165-48174.
148. Watanabe A, Takio K, Ihara Y. 1999. Deamidation and isoaspartate formation in smeared tau in paired helical filaments. Unusual properties of the microtubule-binding domain of tau. J Biol Chem 274: 7368-7378.
149. Wegner A, Engel J. 1975. Kinetics of the cooperative association of actin to actin filaments. Biophys Chem 3:215-225.
150. Wille H, Drewes G, Biernat J, Mandelkow EM, Mandelkow E. 1992. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J Cell Biol 118:573-584.
151. Wilson DM, Binder LI. 1997. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150:2181-2195.
152. Winsor CP. 1932. The Gompertz curve as a growth curve. Proc Natl Acad Sci U S A 18:1-8.
153. Wischik CM, Edwards PC, Lai RY, Gertz HN, Xuereb JH, Paykel ES, Brayne C, Huppert FA, Mukaetova-Ladinska EB, Mena R, et al. 1995. Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Neurobiol Aging 16:409-417.
154. Wyatt PJ. 1993. Light-scattering and the absolute characterization of macromolecules. Anal Chim Acta 272:1-40.
155. Xu S, Lin B. 2001. The mechanism of oxidation-induced low-density lipoprotein aggregation: an analogy to colloidal aggregation and beyond? Biophys J 81:2403-2413.
156. Xu S, Bevis B, Arnsdorf MF. 2001. The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation? Biophys J 81:446-454.
157. Xu S, Wu D, Arnsdorf M, Johnson R, Getz GS, Cabana VG. 2005. Chemical colloids versus biological colloids: a comparative study for the elucidation of the mechanism of protein fiber formation. Biochemistry 44:5381-5389.
158. Zeide B. 1993. Analysis of growth equations. Forest Sci 39:594-616.
159. Zhang Q, Powers ET, Nieva J, Huff ME, Dendle MA, Bieschke J, Glabe CG, Eschenmoser A, Wentworth Jr P, Lerner RA, Kelly JW. 2004. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci U S A 101:4752-4757.
160. Zhao D, Moore JS. 2003. Nucleation-elongation: a mechanism for cooperative supramolecular polymerization. Org Biomol Chem 1:3471-3491.